Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient’s Body Mass Index
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient’s Body Mass Index
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-03-06
DOI
10.1093/jnci/djy042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis
- (2017) Xiaoping Zhao et al. Scientific Reports
- Comparison Between the Effects of Intravenous Morphine, Tramadol, and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy
- (2016) Mohamed A.-E.-M. Bakr et al. CLINICAL JOURNAL OF PAIN
- Body Fatness and Cancer — Viewpoint of the IARC Working Group
- (2016) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications
- (2016) Valeria Simone et al. ONCOLOGIST
- Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
- (2016) Ryan Kolb et al. Nature Communications
- Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis
- (2015) María de Pedro et al. BREAST CANCER RESEARCH AND TREATMENT
- A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients
- (2015) Y. Guo et al. CLINICAL CANCER RESEARCH
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
- (2015) Y. Guo et al. MOLECULAR CANCER THERAPEUTICS
- Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women
- (2015) Sumie Kato et al. Oncotarget
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases
- (2015) Tudor I. Oprea et al. PLoS One
- Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery
- (2014) P. Forget et al. BRITISH JOURNAL OF ANAESTHESIA
- R-ketorolac as a GTPase inhibitor: Phase 0 intraperitoneal pharmacokinetic and biologic activity in ovarian cancer patients
- (2014) C. Muller et al. GYNECOLOGIC ONCOLOGY
- Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery
- (2013) Patrice Forget et al. ANNALS OF SURGICAL ONCOLOGY
- Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice
- (2011) Jian-Wei Gu et al. CANCER BIOLOGY & THERAPY
- The Role of the Perioperative Period in Recurrence After Cancer Surgery
- (2010) Antje Gottschalk et al. ANESTHESIA AND ANALGESIA
- Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis
- (2010) Patrice Forget et al. ANESTHESIA AND ANALGESIA
- Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways
- (2008) Tamara Jaffe et al. INTERNATIONAL JOURNAL OF CANCER
- Mammalian Rho GTPases: new insights into their functions from in vivo studies
- (2008) Sarah J. Heasman et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation